title: Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
abstract: Antisense oligodeoxynucleotides (ODNs) are capable of inhibiting gene expression via a RNase H mechanism in which the complementary RNA is degraded by RNase H. C-5 propyne dU phosphorothioate ODNs bind selectively and with high affinity to RNA within cells leading to potent antisense inhibition of RNA translation. The effect that increasing steric bulk of C-5-substituted deoxyuridine analogs has on affinity for RNA and ability to inhibit gene expression is discussed. The relative binding affinity was measured by thermal denaturation (Tm) analysis, and antisense activity was determined by inhibition of SV40 T-antigen (TAg) expression in CV1 cells. The results show that antisense activity is not directly correlated to Tm measurements. In vitro analysis (RNase H cleavage, on-rates, and off-rates) and pre-formed ODN/RNA experiments indicate that RNase H activity and intracellular dissociation appear to be major determinants of the antisense potency of the various substituted ODNs. The results of our analysis point to the unique ability of C-5 propyne dU ODNs to selectively bind to RNA within cells and activate cleavage of RNA by RNase H leading to potent inhibition of gene expression.
authors.affiliation: Gilead Sciences, Foster City, California 94404, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Gutierrez
authors.forename: M D
authors.initials: MD
authors.lastname: Matteucci
authors.forename: D
authors.initials: D
authors.lastname: Grant
authors.forename: S
authors.initials: S
authors.lastname: Matsumura
authors.forename: R W
authors.initials: RW
authors.lastname: Wagner
authors.forename: B C
authors.initials: BC
authors.lastname: Froehler
mesh_terms: D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects*; D007700:Kinetics; D008845:Microinjections; D015394:Molecular Structure; D016376:Oligonucleotides, Antisense / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D018075:RNA, Complementary / Q000235:genetics / Q000378:metabolism; D016914:Ribonuclease H / Q000378:metabolism
chemical_list: D000952:Antigens, Polyomavirus Transforming; D016376:Oligonucleotides, Antisense; D018075:RNA, Complementary; D016914:Ribonuclease H